Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency
Stefano Fontana, Behrouz Mansouri Taleghani(University of Bern), Lorenzo Alberio(University of Lausanne), Bernhard Lämmle(Johannes Gutenberg University Mainz), Johanna A. Kremer Hovinga(University of Bern), Jan–Dirk Studt(University of Zurich)
Cited by 41
Related Papers
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication
|Thrombosis and Haemostasis|1994|107
Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion
|Archives of Gynecology and Obstetrics|2019|96
Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia
|The American Journal of Medicine|2003|72
Familial Clustering of High Factor VIII Levels in Patients With Venous Thromboembolism
|Arteriosclerosis Thrombosis and Vascular Biology|2001|70